| Financial Year |
March 31 2023 |
| Monetary Funds |
3,263,085,181.63 |
| Held-for-trading Financial Assets |
27,795,000.00 |
| Notes Receivable |
742,041,689.06 |
| Accounts Receivable |
531,557,902.72 |
| Advances to Suppliers |
194,174,129.21 |
| Other Receivables |
12,825,680.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
952,739,517.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
186,672,336.56 |
| Total Current Assets |
6,015,859,769.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,000.00 |
| Investment Properties |
17,025,560.91 |
| Fixed Assetes |
4,248,374,964.26 |
| Under-construction Projects |
1,224,686,370.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
445,006,837.73 |
| R&D expenses |
-- |
| Goodwill |
5,578,914.89 |
| Long-Term Deferred and Prepaid Expenses |
1,135,141.67 |
| Deferred Income Tax Assets |
64,052,899.69 |
| Other Non-Current Assets |
521,833,020.70 |
| Sub-Total of Non-Current Assets |
7,494,489,047.76 |
| Total Assets |
13,510,348,816.94 |
| Short-Term Loans |
2,529,990,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
870,163,398.38 |
| Accounts Payable |
693,802,163.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
96,955,562.84 |
| Taxes Payable |
24,510,111.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
188,770,995.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
236,811,878.87 |
| Other Current Liabilities |
60,828,968.59 |
| Sub-Total of Current Liabilities |
4,839,371,776.86 |
| Long-term Loans |
210,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
98,637,718.65 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
100,187,671.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
710,573,953.51 |
| Total Liabilities |
5,549,945,730.37 |
| Paid-In Capital(Or Share Stock) |
2,159,249,374.00 |
| Capital Surplus |
1,675,949,250.62 |
| Surplus Reserve |
445,403,409.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,147,036,992.88 |
| Minority Stockholder's Interest |
38,019,358.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,922,383,728.39 |
| Owner's Equity（Stockholder's Equity） |
7,960,403,086.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,510,348,816.94 |
